...
首页> 外文期刊>Expert opinion on therapeutic targets >FOXP1: a potential therapeutic target in cancer.
【24h】

FOXP1: a potential therapeutic target in cancer.

机译:FOXP1:潜在的癌症治疗靶点。

获取原文
获取原文并翻译 | 示例
           

摘要

Forkhead Box P1 (FOXP1) is a member of the FOX family of transcription factors which have a broad range of functions. Foxp1 is widely expressed and has been shown to have a role in cardiac, lung and lymphocyte development. FOXP1 is targeted by recurrent chromosome translocations and its overexpression confers a poor prognosis in a number of types of lymphomas, suggesting it may function as an oncogene. In contrast, FOXP1 localises to a tumour suppressor locus at 3p14.1 and loss of FOXP1 expression in breast cancer is associated with a worse outcome, suggesting FOXP1 may function as a tumour suppressor in other tissue types. These data suggest that FOXP1 may not only be useful in prognosis but also may be used to develop FOXP1-directed therapeutic strategies.
机译:叉头盒P1(FOXP1)是具有广泛功能的FOX转录因子家族的成员。 Foxp1被广泛表达,并已显示在心脏,肺和淋巴细胞发育中起作用。 FOXP1是复发性染色体易位的靶点,它的过表达使许多类型的淋巴瘤的预后不良,表明它可能是癌基因。相反,FOXP1定位于3p14.1处的抑癌基因,乳腺癌中FOXP1表达的丧失与较差的结局相关,这表明FOXP1可能在其他组织类型中起抑癌作用。这些数据表明,FOXP1不仅可以用于预后,而且可以用于开发以FOXP1为导向的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号